2 unknown, 1 recruiting. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Unknown 2, Recruiting 1 |
Follow HDM1002: new trials by email Literature Review of HDM1002 trials Research Report on HDM1002
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin Metformin, Empagliflozin, Midazolam - Overweight Subject, Healthy Subjects | Phase 1 | Recruiting | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 111 | 2025-09-24 | 2026-01-09 |
| A Drug-Drug Interaction (DDI) Study of HDM1002 With Repaglinide, Atorvastatin, Digoxin and Rosuvastatin in Healthy Subjects and Overweight Subjects. Repaglinide, Atorvastatin, Digoxin - Healthy Adult Subject, Overweight Subject | Phase 1 | Unknown | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 30 | 2024-10-01 | 2024-09-23 |
| A Relative Bioavailability and Food Effect Study of HDM1002 in Healthy Subjects HDM1002 - Healthy Adult Subject | Phase 1 | Unknown | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 33 | 2024-10-01 | 2024-09-23 |
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. (3)
China (3)